Sulfadoxin

Sulfadoxine

HCID 17134CAS 2447-57-6

Grundinformationen

Standard-SMILES
COc1ncnc(NS(=O)(=O)c2ccc(N)cc2)c1OC
InChIKey
PJSFRIWCGOHTNF-UHFFFAOYSA-N
Summenformel
C12H14N4O4S
Durchschnittliche Molmasse
310,33 g/mol
Monoisotopische Masse
310,07357593

Überblick

Sulfadoxine is a sulfonamide consisting of pyrimidine having methoxy substituents at the 5- and 6-positions and a 4-aminobenzenesulfonamido group at the 4-position. In combination with the antiprotozoal pyrimethamine (CHEBI:8673) it is used as an antimalarial. It has a role as an antibacterial drug and an antimalarial. It is a sulfonamide and a member of pyrimidines.

Namen und Bezeichner

Bevorzugter Name
Sulfadoxine
IUPAC
4-amino-N-(5,6-dimethoxypyrimidin-4-yl)benzenesulfonamide
Lokaler Name
Sulfadoxin
Englischer Name
Sulfadoxine
Summenformel
C12H14N4O4S
Molmasse
310.33

Namen und Synonyme

SULFADOXINE2447-57-6SulphadoxineSulfadoxinSulforthomidine4-amino-N-(5,6-dimethoxypyrimidin-4-yl)benzenesulfonamideSulphormethoxineSulfadoxinumSulfadoxinaFanzilRo 4-4393Benzenesulfonamide, 4-amino-N-(5,6-dimethoxy-4-pyrimidinyl)-
Weitere Namen anzeigen
4-AMINO-N-(5,6-DIMETHOXY-4-PYRIMIDINYL)BENZENESULFONAMIDESulfadimoxineSulfadumoxinewr4873fanasil
Fanasulf4-Sulfanilamido-5,6-dimethoxypyrimidineDTXSID6023608Ro-4-4393N'-(5,6-Dimethoxy-4-pyrimidyl)sulfanilamideRo-44393NSC-759319Sulformethoxine

Datenbank-Bezeichner

CAS
2447-57-6
PubChem CID
17134
DTXSID
DTXSID6023608
ChEMBL
CHEMBL1539、CHEMBL244800
ChEBI
CHEBI:9329
UNII
88463U4SM5
EC Number
219-504-9
Nikkaji
J21.373J

Eigenschaften

Berechnete Struktureigenschaften

XLogP
0,7
Polarare Oberfläche (TPSA)
125 Ų
H-Brücken-Donoren
2
H-Brücken-Akzeptoren
8
Frei drehbare Bindungen
5
Schwere Atome
21

Experimentelle und physikochemische Eigenschaften

Drugs · 3 Einträge

Pharmaceuticals -> Antibiotics

Pharmaceuticals -> Antibiotics (Sulfonamide)

Pharmaceuticals -> Listed in ZINC15

LogP · 2 Einträge

0.70

0.7

Solubility2.96e-01 g/L
Human Drugs · 2 Einträge

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Animal DrugsPharmaceuticals -> Animal Drugs -> Approved in Taiwan
Melting Point · 2 Einträge

190-194 °C

190 - 194 °C

Physikochemische Eigenschaften

Schmelzpunkt
190 · 190-194°C
Siedepunkt
298 °C · 298°C (rough estimate)
Dichte
1.4006 · 1.4006 (rough estimate)
Brechungsindex
1.627 · 1.6270 (estimate)
storage temp.
Keep in dark place,Inert atmosphere,Room temperature
Löslichkeit
Soluble in ethanol & ammonium hydroxide (9:1) at 20mg/ml

Sicherheit und Regulatorisches

GHS-Klassifizierung

GHS Classification · 4 Einträge

Warning

H315 (57.7%): Causes skin irritation [Warning Skin corrosion/irritation]

P261, P264, P264+P265, P271, P272, P273, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P333+P317, P337+P317, P362+P364, P391, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 130 reports by companies from 9 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Gefahrenhinweise

Other Safety InformationIMAP assessments - Benzenesulfonamide, 4-amino-N-(5,6-dimethoxy-4-pyrimidinyl)-: Environment tier I assessment
Hazard Classes and CategoriesSkin Irrit. 2 (57.7%)

Sicherheitsdaten

wgk
2
hs_code
29350090
RTECS-Nr.
DA9500000
risk_code
36/37/38
Toxizität
LD50 in mice (microcrystals, mg/kg): 5200 orally, 2900 s.c., 2900 i.p. (Bhni)
hazard_code
Xi

Chemie und Industrie

Pharmakologische Informationen

ATC CodeQJ - Antiinfectives for systemic use
Pharmacodynamics · 1 Eintrag

Sulfadoxine helps inhibit the enzyme dihydropteroate synthetase which is an enzyme necessary in the conversion of PABA to folic acid. As folic acid is vital to the synthesis, repair, and methylation of DNA which is vital to cell growth in Plasmodium falciparum. With this vital nutrient lacking, the parasite has difficulty in reproducing.

Mechanism of Action · 1 Eintrag

Sulfadoxine is a sulfa drug, often used in combination with pyrimethamine to treat malaria. This medicine may also be used to prevent malaria in people who are living in, or will be traveling to, an area where there is a chance of getting malaria. Sulfadoxine targets Plasmodium dihydropteroate synthase and dihydrofolate reductase. Sulfa drugs or Sulfonamides are antimetabolites. They compete with para-aminobenzoic acid (PABA) for incorporation into folic acid. The action of sulfonamides exploits the difference between mammal cells and other kinds of cells in their folic acid metabolism. All cells require folic acid for growth. Folic acid (as a vitamin) diffuses or is transported into human cells. However, folic acid cannot cross bacterial (and certain protozoan) cell walls by diffusion or active transport. For this reason bacteria must synthesize folic acid from p-aminobenzoic acid.

FDA Pharmacological Classification · 5 Einträge

88463U4SM5

SULFADOXINE

Established Pharmacologic Class [EPC] - Sulfonamide

Chemical Structure [CS] - Sulfonamides

Sulfadoxine is a Sulfonamide.

MeSH Pharmacological Classification · 3 Einträge

Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection.

Substances capable of killing agents causing urinary tract infections or of preventing them from spreading.

Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585)

Verwendung und Herstellung

Use ClassificationPharmaceuticals -> Animal Drugs -> Approved in Taiwan
Anwendungen · 1 Eintrag

BeschreibungSulfadoxin is a sulfonamide antibiotic that inhibits dihydropteroate synthetase (DHPS), an enzyme involved in folic acid synthesis. Sulfadoxin competes with 4-aminobenzoate (PABA), the native substrate of DHPS, and inhibits PABA incorporation into folic acid. Folate is essential for purine and pyrimidine synthesis, therefore, sulfadoxin has antiproliferative activity in non-resistant P. falciparum. Sulfadoxin inhibits growth of P. falciparum in vitro, but potency varies between non-resistant (IC50 = 4 ng/ml) and resistant strains (IC50 = 3,970 ng/ml).

Vor- und nachgelagerte Produkte

Vorgelagerte Rohstoffe

Nachgelagerte Produkte

Anbieter50 Anbieter

国药集团化学试剂有限公司86-21-63210123 · [email protected]
北京华美互利生物化工010-56205725 · [email protected]
梯希爱(上海)化成工业发展有限公司021-67121386 · [email protected]
上海阿拉丁生化科技股份有限公司400-6206333 13167063860 · [email protected]
Shandong chuangyingchemical Co., Ltd.18853181302 · [email protected]
Ergänzende Hinweise · 1 Eintrag

DefinitionChEBI: A sulfonamide consisting of pyrimidine having methoxy substituents at the 5- and 6-positions and a 4-aminobenzenesulfonamido group at the 4-position. In combination with the antiprotozoal pyrimethamine (CHEBI:8673) it is used as an antimalarial.

Zugehörige Reaktionen

2

Verknüpfte Notizen

Wird geladen…